Outpatient pulmonary rehabilitation in patients with chronic obstructive pulmonary disease

Shahin Barakat, Germain Michele, Pastene George, Viallet Nicole, Annat Guy, Shahin Barakat, Germain Michele, Pastene George, Viallet Nicole, Annat Guy

Abstract

Objective: To evaluate an entirely outpatient-based program of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease COPD, using St.George's Respiratory questionnaire (SGRQ), the 6-minutes walking test (6-MWT) and BODE index as the primary outcome measures.

Methods: A prospective, parallel-group controlled study of an outpatient rehabilitation program in 80 patients with COPD (67 men and 13 women; mean age 64.8 +/- 10.6 years; FEV1, 42.8% +/- 7.6% of the predicted value. The active group (n = 40) took part in a 14-week rehabilitation program [3 h/wk, 1.5 h of education and exercise and 1.5 h of cycling]. The control group (n = 40) was reviewed routinely as medical outpatients. The following evaluations were carried out at study entry and afterl4 weeks: (1) pulmonary function studies; (2) 6-minutes walking test 6MWT; (3) quality of life; and (4) BODE index.

Results: The following patients completed the study: 35 patients (87.5%) from the active group (mean age, 63.7 +/- 11.9 years; mean forced expiratory volume in one second (FEV1), 41.9 +/- 2.6% of the predicted value); and 36 patients (88%) from the control group (mean age, 65.9 +/- 10.3 years; mean FEV1, 43.33 +/- 3.6% of the predicted value). We found no changes in pulmonary function parameters in the active group and the control one at 14weeks. On the other hand, there were significant changes within the components of the SGRQ (12.3 for the score total) for the patients of the active group but not for the patients of the control one (only 1.5 for the score total), we observed also a significant increase in the distance of the 6-MWT in the patients of the active group but not for the patients of the control one, and finally a decrease of two points (from 6 to 4) was noted in the score of the active group's BODE index without any change in the control group's one.

Conclusion: An outpatient-based of 14-week rehabilitation program significantly improved the quality of life and exercise tolerance without any change in the pulmonary function in patients with moderate COPD, and there was also a large decrease in the risk of death in rehabilitated patients as measured using the BODE index.

References

    1. Agusti AG. Systemic effects of chronic obstructive pulmonary disease. Proc Am Thoracic Soc. 2005;2:367–370. Discussion 371–2.
    1. American College of Chest Physicians (ACCP) Pulmonary Rehabilitation Joint ACCP/AACVPR Evidence-Based Guidelines. Chest. 1997;112:1363–96.
    1. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am Rev Respir Crit Care Med. 1995;152:S77–120.
    1. American Thoracic Society, European Respiratory Society. Skeletal muscle dysfunction in chronic obstructive pulmonary disease: a statement of the American Thoracic Society and European Respiratory Society. Am J Respir Crit Care Med. 1999;159:S1–40.
    1. American Thoracic Society. Pulmonary Rehabilitation Guideline Panel. Am J Respir Crit Care Med. 1999;159:1666–82.
    1. Bartolome R, Cilli CG, Cote JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:1005–12.
    1. Bittner V, Weiner DH, Yusuf S, et al. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction [abstract] JAMA. 1993;270:1702–7.
    1. Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005;294:716–24.
    1. California Pulmonary Rehabilitation Collaborative Group. Effects of pulmonary rehabilitation of dyspnoea, quality of life, and healthcare costs in California. J Cardiopulm Rehabil. 2004;24:52–62.
    1. Celli BR, MacNee W. Standard for diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23:932–46.
    1. Curtis JR, Deyo RA, Hudson LD. Health-related quality of life among patients with chronic obstructive pulmonary disease. Thorax. 1994;49:162–70.
    1. Debigare R, Cote CH, Maltais F. Peripheral muscle wasting in chronic obstructive pulmonary disease: clinical relevance and mechanisms. Am J Respir Crit Care Med. 2001;164:1712–17.
    1. Decramer M, Gosselink R, Toosters T, et al. Muscle weakness is related to utilization of health care resources in COPD patients. Eur Respir J. 1997;10:417–23.
    1. Decramer M, Gosselink R, Toosters T, et al. Peripheral muscle force in a determinant of survival in COPD. Eur Respir J. 1998;12:2615.
    1. Engostrom CP, Persson LO, Larsson S, et al. Long-term effects of a pulmonary rehabilitation programme in outpatients with chronic obstructive pulmonary disease: a randomized controlled study. Scand J Rehab Med. 1999;31:207–13.
    1. Fabbri LM, Hurd SS. Global strategy for the diagnosis, management, and prevention of COPD: 2003 update. Eur Respir J. 2003;22:1–2.
    1. Fishman AP. One hundred years of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;171:941–8.
    1. Gerardi DA, Lovett L, Benoit-Connors ML, et al. Variables related to increased mortality following outpatient pulmonary rehabilitation [abstract] Eur Respir J. 1996;9:431–5.
    1. Gigliotti F, Coli C, Bianchi R, et al. Exercise training improves exertional dyspnoea in patients with COPD: evidence of the role of mechanical factors. Chest. 2003;123:1794–802.
    1. Global Initiative for Chronic Obstructive Lung Disease. Workshop Report, Global Strategy for Diagnosis, Management, and Prevention of COPD. Bethesda, MD: National Institutes of Health, National Heart, Lung and Blood Institute; 2005. Update Sept. 2005. 2005 [online]. Accessed on 5 October 2007 URL:
    1. Griffiths TL, Burr ML, Campbell IA, et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomized controlled trial. Lancet. 2000;355:362–8.
    1. Guyatt G, Townsend M, Keller J, et al. Measuring functional status in chronic lung disease: conclusions from a randomized control trial. J Respir Med. 1989;83:293–7.
    1. Jones PW, Quirk FH, Baveystock CM. The St George’s Respiratory Questionnaire. J Respir Med. 1991;85(Suppl B):25–31.
    1. Jones PW, Quirk FH, Baveystock CM, et al. A self-complete measure of health status for chronic airflow limitations: the St George’s respiratory questionnaire. Am Rev Respir Dis. 1992;145:1321–7.
    1. Kakizaki F, Shibuya M, Yamazaki T, et al. Preliminary report on the effects of respiratory muscle stretch gymnastics on chest wall mobility in patients with chronic obstructive pulmonary disease. Respir Care. 1999;44:409–14.
    1. Lacasse Y, Wong E, Guyatt GH, et al. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet. 1996;348:1115–19.
    1. Laghi F, Tobin MJ. Disorders of the respiratory muscles. Am J Respir Crit Care Med. 2003;168:10–48.
    1. MacNee W. Pulmonary and systemic oxidant /antioxidant imbalance in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2:50–60.
    1. Man WD, Hopkinson NS, Harraf F, et al. Abdominal muscle and quadriceps strength in chronic obstructive pulmonary disease. Thorax. 2005;60:718–22.
    1. Marquis K, Debigare R, Lacasse Y, et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;166:809–13.
    1. Mercken EM, Hageman GJ, Schols AM, et al. Rehabilitation decreases exercise-induced oxidative stress in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;172:994–1001.
    1. Nishimura K, Izumi T, Tsukino M, et al. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest. 2002;121:1434–40.
    1. Ottenheijm CA, Heunks LM, Sieck GC, et al. Diaphragm dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;172:200–5.
    1. Oudijk EJ, Nijhuis EH, Zwank MD, et al. Systemic inflammation in COPD visualised by gene profiling in peripheral blood neutriphils. Thorax. 2005;60:538–44.
    1. Pitta F, Toosters T, Spruit MA, et al. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;171:972–7.
    1. Quirk FH, Baveystock CM, Wilson RC, et al. Influence of demographic and disease related factors on the degree of distress associated with symptoms and restrictions on the daily living due to asthma in six countries. Eur Respir Dis. 1991;4:167–71.
    1. Redelmeier DA, Bayoumi AM, Goldstein RS, et al. Interpreting small differences in functional status: The six minute walk test in chronic lung disease patients [abstract] Am J Respir Crit Care Med. 1997;155:1278–82.
    1. Rennard SI, Calverley P. Rescue Therapy and paradox of the Barcalounger. Eur Respir J. 2003;21:916–17.
    1. Ries AL, Kaplan RM, Limberg TM, et al. Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Ann Intern Med. 1995;122:823–32.
    1. Shapiro SD, Ingenito EP. The pathogenesis of chronic obstructive pulmonary disease: advances in the past 100 years. Am J Respir Cell Mol Biol. 2005;32:367–72.
    1. Sin DD, Lacy P, York E, et al. Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;170:760–5.
    1. Strong K, Mathers C, Leeder S, et al. Preventing chronic diseases: how many lives can we save? Lancet. 2005;366:1578–82.
    1. Tapson VF. The role of smoking in coagulation and thromboembolism in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2:71–7.
    1. Troosters T, Casaburi R, Gosselink R, et al. Pulmonary rehabilitation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;172:19–38.
    1. Verrill D, Borton C, Beasley W, et al. The effects of short-term and long term pulmonary rehabilitation on functional capacity, perceived dyspnoea, and quality of life. Chest. 2005;128:673–83.
    1. Wijkstra PJ, Van Altena R, Kraan J, et al. Quality of life in patients with chronic obstructive pulmonary disease improves after rehabilitation at home. Eur Respir J. 1994;7:269–73.
    1. Wouters EF. Local and systemic inflammation in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2:26–33.
    1. Yasuda H, Yamaya M, Nakayama K, et al. Increased arterial carboxyhemoglobin concentrations in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;171:1246–51.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅